Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment

World Journal of Gastroenterology

Volumn 22, Issue 10, 2016, Pages 2993-3005

  Yang, Wei ^a   Yan, Kun ^a   Goldberg, S Nahum ^b,c   Ahmed, Muneeb ^a   Lee, Jung Chieh ^a   Wu, Wei ^a   Zhang, Zhong Yi ^a   Wang, Song ^a   Chen, Min Hua ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Hepatocellular carcinoma; Long term survival; Percutaneous; Radiofrequency ablation; Ultrasonography guided

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BILIARY TRACT DISEASE; BURN; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD PUGH SCORE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; ECHOGRAPHY; ELECTRODE; FEMALE; FOLLOW UP; GALLBLADDER DISEASE; HUMAN; HUMAN TISSUE; INTESTINE PERFORATION; LABORATORY TEST; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLEURA EFFUSION; PORTAL HYPERTENSION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFLAMMATION; PREOPERATIVE EVALUATION; PROGRESSION FREE SURVIVAL; RADIOFREQUENCY ABLATION; RADIOFREQUENCY ABLATION DEVICE; REAL TIME ULTRASOUND SCANNER; RETROSPECTIVE STUDY; SEPTIC SHOCK; SURVIVAL RATE; SURVIVAL TIME; TISSUE ADHESION; TREATMENT RESPONSE; TUMOR GROWTH; ULTRASONOGRAPHY GUIDED PERCUTANEOUS RADIOFREQUENCY ABLATION; ADVERSE EFFECTS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84960471567     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i10.2993     Document Type: Article

References (37)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917 [PMID: 14667750 DOI: 10.1016/S0140-6736(03)14964-1]
2. Song TJ, Ip EW, Fong Y. Hepatocellular carcinoma: current surgical management. Gastroenterology 2004; 127: S248-S260 [PMID: 15508091 DOI: 10.1053/j.gastro.2004.09.039]
3. N'Kontchou G, Mahamoudi A, Aout M, Ganne-Carrié N, Grando V, Coderc E, Vicaut E, Trinchet JC, Sellier N, Beaugrand M, Seror O. Radiofrequency ablation of hepatocellular carcinoma: longterm results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 2009; 50: 1475-1483 [PMID: 19731239 DOI: 10.1002/hep.23181]
4. Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y, Fujishima T, Yoshida H, Kawabe T, Omata M. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103: 1201-1209 [PMID: 15690326 DOI: 10.1002/cncr.20892]
5. Lencioni R, Cioni D, Crocetti L, Franchini C, Pina CD, Lera J, Bartolozzi C. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234: 961-967 [PMID: 15665226 DOI: 10.1148/radiol.2343040350]
6. Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, Rossi S. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 2008; 47: 82-89 [PMID: 18008357 DOI: 10.1002/hep.21933]
7. Raut CP, Izzo F, Marra P, Ellis LM, Vauthey JN, Cremona F, Vallone P, Mastro A, Fornage BD, Curley SA. Significant longterm survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol 2005; 12: 616-628 [PMID: 15965731]
8. Choi D, Lim HK, Rhim H, Kim YS, Lee WJ, Paik SW, Koh KC, Lee JH, Choi MS, Yoo BC. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 2007; 17: 684-692 [PMID: 17093964]
9. Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Sato T, Masuzaki R, Kondo Y, Goto T, Yoshida H, Omata M, Koike K. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol 2012; 107: 569-577; quiz 578 [PMID: 22158026 DOI: 10.1038/ajg.2011.425]
10. Peng ZW, Zhang YJ, Chen MS, Lin XJ, Liang HH, Shi M. Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results. Eur J Surg Oncol 2010; 36: 1054-1060 [PMID: 20846819 DOI: 10.1016/j.ejso.2010.08.133]
11. Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022 [PMID: 21374666 DOI: 10.1002/hep.24199]
12. Zwiebel WJ. Sonographic diagnosis of hepatic vascular disorders. Semin Ultrasound CT MR 1995; 16: 34-48 [PMID: 7718281]
13. Chen MH, Yang W, Yan K, Zou MW, Solbiati L, Liu JB, Dai Y. Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients-mathematic model, overlapping mode, and electrode placement process. Radiology 2004; 232: 260-271 [PMID: 15166323 DOI: 10.1148/radiol.2321030821]
14. Chen MH, Yang W, Yan K, Hou YB, Dai Y, Gao W, Zhang H, Wu W. Radiofrequency ablation of problematically located hepatocellular carcinoma: tailored approach. Abdom Imaging 2008; 33: 428-436 [PMID: 17639375]
15. Chen MH, Wei Y, Yan K, Gao W, Dai Y, Huo L, Yin SS, Zhang H, Poon RT. Treatment strategy to optimize radiofrequency ablation for liver malignancies. J Vasc Interv Radiol 2006; 17: 671-683 [PMID: 16614151]
16. Yang W, Yan K, Wu GX, Wu W, Fu Y, Lee JC, Zhang ZY, Wang S, Chen MH. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes. World J Gastroenterol 2015; 21: 1554-1566 [PMID: 25663774 DOI: 10.3748/wjg.v21.i5.1554]
17. Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD, Dupuy DE, Gervais DA, Gillams AR, Kane RA, Lee FT, Livraghi T, McGahan J, Phillips DA, Rhim H, Silverman SG, Solbiati L, Vogl TJ, Wood BJ, Vedantham S, Sacks D. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 2009; 20: S377-S390 [PMID: 19560026 DOI: 10.1016/j.jvir.2009.04.011]
18. Goldberg SN, Charboneau JW, Dodd GD, Dupuy DE, Gervais DA, Gillams AR, Kane RA, Lee FT, Livraghi T, McGahan JP, Rhim H, Silverman SG, Solbiati L, Vogl TJ, Wood BJ. Imageguided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003; 228: 335-345 [PMID: 12893895 DOI: 10.1148/radiol.2282021787]
19. Yan K, Chen MH, Yang W, Wang YB, Gao W, Hao CY, Xing BC, Huang XF. Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors. Eur J Radiol 2008; 67: 336-347 [PMID: 17765421 DOI: 10.1016/j.ejrad.2007.07.007]
20. Machi J, Bueno RS, Wong LL. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma. World J Surg 2005; 29: 1364-1373 [PMID: 16240062]
21. Kim YS, Lim HK, Rhim H, Lee MW, Choi D, Lee WJ, Paik SW, Koh KC, Lee JH, Choi MS, Gwak GY, Yoo BC. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol 2013; 58: 89-97 [PMID: 23023009 DOI: 10.1016/j.jhep.2012.09.020]
22. Kim SH, Choi SB, Lee JG, Kim SU, Park MS, Kim do Y, Choi JS, Kim KS. Prognostic factors and 10-year survival in patients with hepatocellular carcinoma after curative hepatectomy. J Gastrointest Surg 2011; 15: 598-607 [PMID: 21336497 DOI: 10.1007/s11605-011-1452-7]
23. Giuliante F, Ardito F, Pinna AD, Sarno G, Giulini SM, Ercolani G, Portolani N, Torzilli G, Donadon M, Aldrighetti L, Pulitanò C, Guglielmi A, Ruzzenente A, Capussotti L, Ferrero A, Calise F, Scuderi V, Federico B, Nuzzo G. Liver resection for hepatocellular carcinoma ≤3 cm: results of an Italian multicenter study on 588 patients. J Am Coll Surg 2012; 215: 244-254 [PMID: 22634119 DOI: 10.1016/j.jamcollsurg.2012.04.013]
24. Lam VW, Ng KK, Chok KS, Cheung TT, Yuen J, Tung H, Tso WK, Fan ST, Poon RT. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg 2008; 207: 20-29 [PMID: 18589357 DOI: 10.1016/j.jamcollsurg.2008.01.020]
25. Li L, Zhang J, Liu X, Li X, Jiao B, Kang T. Clinical outcomes of radiofrequency ablation and surgical resection for small hepatocellular carcinoma: A meta-analysis. J Gastroenterol Hepatol 2012; 27: 51-58 [PMID: 22004366 DOI: 10.1111/j.1440-1746.2011.06947.x]
26. Hsieh CB, Chang HM, Chen TW, Chen CJ, Chan DC, Yu JC, Liu YC, Chang TM, Shen KL. Comparison of transcatheter arterial chemoembolization, laparoscopic radiofrequency ablation, and conservative treatment for decompensated cirrhotic patients with hepatocellular carcinoma. World J Gastroenterol 2004; 10: 505-508 [PMID: 14966906 DOI: 10.3748/wjg.v10.i4.505]
27. Kim YK, Kim CS, Chung GH, Han YM, Lee SY, Jin GY, Lee JM. Radiofrequency ablation of hepatocellular carcinoma in patients with decompensated cirrhosis: evaluation of therapeutic efficacy and safety. AJR Am J Roentgenol 2006; 186: S261-S268 [PMID: 16632686]
28. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients: The Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998; 28: 751-755 [PMID: 9731568 DOI: 10.1002/hep.510280322]
29. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 1999; 19: 329-338 [PMID: 10518312 DOI: 10.1055/s-2007-1007122]
30. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005; 242: 158-171 [PMID: 16041205 DOI: 10.1097/01.sla.0000171032.99149. fe]
31. Lupo L, Panzera P, Giannelli G, Memeo M, Gentile A, Memeo V. Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB (Oxford) 2007; 9: 429-434 [PMID: 18345289 DOI: 10.1080/13651820701713758]
32. Harrison LE, Koneru B, Baramipour P, Fisher A, Barone A, Wilson D, Dela Torre A, Cho KC, Contractor D, Korogodsky M. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg 2003; 197: 759-764 [PMID: 14585410 DOI: 10.1016/S1072-7515(03)00750-6]
33. Zhang YJ, Liang HH, Chen MS, Guo RP, Li JQ, Zheng Y, Zhang YQ, Lau WY. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: A prospective randomized trial. Radiology 2007; 244: 599-607 [PMID: 17641378 DOI: 10.1148/radiol.2442060826]
34. Gillams AR, Lees WR. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 2009; 19: 1206-1213 [PMID: 19137310 DOI: 10.1007/s00330-008-1258-5]
35. Yamamoto K, Imamura H, Matsuyama Y, Hasegawa K, Beck Y, Sugawara Y, Makuuchi M, Kokudo N. Significance of alphafetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy. Ann Surg Oncol 2009; 16: 2795-2804 [PMID: 19669841 DOI: 10.1245/s10434-009-0618-y]
36. Solbiati L, Ierace T, Tonolini M, Cova L. Guidance and control of percutaneous treatments with contrast-enhanced ultrasound. Eur Radiol 2003; 13 Suppl 3: N87-N90 [PMID: 15015887]
37. Chen MH, Yang W, Yan K, Dai Y, Wu W, Fan ZH, Callstrom MR, Charboneau JW. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation. Clin Radiol 2007; 62: 752-760 [PMID: 17604763 DOI: 10.1016/j.crad.2006.12.013]